CCNE2 and neoplasm: Due to the limited availability of antibodies suitable for immunohistochemistry, the expression of cyclin E2 has been examined only through mRNA expression in tumour samples, whereas there is a comprehensive array of literature on the expression of both cyclin E1 protein and mRNA in cancer samples [2,104].